Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
Open Access
- 28 February 2010
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 208 (2), 518-523
- https://doi.org/10.1016/j.atherosclerosis.2009.06.039
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart FailureArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 DiabetesDiabetes Care, 2007
- Predictive Variables for Mortality After Acute Ischemic StrokeStroke, 2007
- Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) studyAmerican Heart Journal, 2006
- ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in HumansStroke, 2006
- The Impact of History of Hypertension and Type 2 Diabetes at Baseline on the Incidence of Stroke and Stroke MortalityStroke, 2005
- Twenty-Five-Year Prediction of Stroke Deaths in the Seven Countries StudyStroke, 1996
- Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.Stroke, 1993
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionThe New England Journal of Medicine, 1984